Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice

Neuroscience

Volumn 254, Issue , 2013, Pages 152-159

  Buskila, Y ^a,b   Crowe, S E ^a   Ellis Davies, G C R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WESTERN SYDNEY UNIVERSITY   (Australia)

Author keywords

5xFAD; In vivo imaging; Synaptic failure

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; LONGITUDINAL STUDY; MOUSE; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEURITIC DYSTROPHY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SOMATOSENSORY CORTEX; STRUCTURE ANALYSIS; SYNAPTIC DECAY; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; ALZHEIMER DISEASE; ANIMAL; BRAIN CORTEX; DISEASE MODEL; NERVE CELL; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PHYSIOLOGY; SYNAPSE;

ALZHEIMER DISEASE; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; LONGITUDINAL STUDIES; MICE; MICE, TRANSGENIC; NEURONS; ORGAN CULTURE TECHNIQUES; SYNAPSES;

EID: 84885724780     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.09.016     Document Type: Article

References (36)

1. Alier K., Ma L., Yang J., Westaway D., Jhamandas J.H. Abeta inhibition of ionic conductance in mouse basal forebrain neurons is dependent upon the cellular prion protein PrPC. J Neurosci 2011, 31:16292-16297.
2. Ashe K.R., Zahs K.H. Probing the biology of Alzheimer's disease in mice. Neuron 2010, 66:631-645.
3. Bender V.A., Bender K.J., Brasier D.J., Feldman D.E. Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex. J Neurosci 2006, 26:4166-4177.
4. Benilova I., Karran E., De Strooper B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 2012, 15:349-357.
5. Bittner T., Fuhrmann M., Burgold S., Ochs S.M., Hoffmann N., Mitteregger G., Kretzschmar H., LaFerla F.M., Herms J. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS ONE 2010, 5:e15477.
6. Bojarski L., Herms J., Kuznicki J. Calcium dysregulation in Alzheimer's disease. Neurochem Int 2008, 52:621-633.
7. Buskila Y., Amitai Y. Astrocytic iNOS-dependent enhancement of synaptic release in mouse neocortex. J Neurophysiol 2010, 103:1322-1328.
8. Chakroborty S., Goussakov I., Miller M.B., Stutzmann G.E. Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. J Neurosci 2009, 29:9458-9470.
9. Crowe S.E., Ellis-Davies G.C.R. In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration. J Comp Neurol 2013, 521:2181-2194.
10. Crowe SE, Ellis-Davies GCR (2013b) Spine pruning in 5xFAD mice starts on basal dendrites of layer 5 pyramidal neurons. Brain Struct Func. Doi:. doi:10.1007/s00429-00013-00518-00426.
11. Devi L., Ohno M. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Eur J Neurosci 2010, 31:110-118.
12. Duyckaerts C., Potier M.C., Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol 2008, 115:5-38.
13. Eimer W.A., Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation. Mol Neurodegener 2013, 8:2.
14. Ellis-Davies G.C.R. Two-photon microscopy for chemical neuroscience. ACS Chem Neurosci 2011, 2:185-197.
15. Espinosa F., Kavalali E.T. NMDA receptor activation by spontaneous glutamatergic neurotransmission. J Neurophysiol 2009, 101:2290-2296.
16. Feldman D.E. The spike-timing dependence of plasticity. Neuron 2012, 75:556-571.
17. Ferreira S.T., Klein W.L. The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem 2011, 96:529-543.
18. Gotz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev 2008, 9:532-544.
19. Holtzman D.M., Morris J.C., Goate A.M. Alzheimer's disease: the challenge of the second century. Sci Transl Med 2011, 3. 77sr71.
20. Jawhar S., Trawicka A., Jenneckens C., Bayer T.A., Wirths O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging 2012, 33(196):e129-e140.
21. Kaczorowski C.C., Sametsky E., Shah S., Vassar R., Disterhoft J.F. Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease. Neurobiol Aging 2011, 32:1452-1465.
22. Kimura R., Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis 2009, 33:229-235.
23. Kimura R., Devi L., Ohno M. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. J Neurochem 2010, 113:248-261.
24. Luebke J.I., Weaver C.M., Rocher A.B., Rodriguez A., Crimins J.L., Dickstein D.L., Wearne S.L., Hof P.R. Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models. Brain Struct Funct 2010, 214:181-199.
25. Marchetti C., Marie H. Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?. Rev Neurosci 2011, 22:373-402.
26. Meyer-Luehmann M., Spires-Jones T.L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., Koenigsknecht-Talboo J., Holtzman D.M., Bacskai B.J., Hyman B.T. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 451:720-724.
27. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006, 26:10129-10140.
28. O'Connor T., Sadleir K.R., Maus E., Velliquette R.A., Zhao J., Cole S.L., Eimer W.A., Hitt B., Bembinster L.A., Lammich S., Lichtenthaler S.F., Hébert S.S., De Strooper B., Haass C., Bennett D.A., Vassar R. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 2008, 60:988-1009.
29. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
30. Ohno M., Cole S.L., Yasvoina M., Zhao J., Citron M., Berry R., Disterhoft J.F., Vassar R. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol Dis 2007, 26:134-145.
31. Randall A.D., Witton J., Booth C., Hynes-Allen A., Brown J.T. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology 2010, 59:243-267.
32. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
33. Wirths O., Erck C., Martens H., Harmeier A., Geumann C., Jawhar S., Kumar S., Multhaup G., Walter J., Ingelsson M., Degerman-Gunnarsson M., Kalimo H., Huitinga I., Lannfelt L., Bayer T.A. Identification of low molecular weight pyroglutamate Aβ oligomers in Alzheimer disease: a novel tool for therapy and diagnosis. J Biol Chem 2010, 285:41517-41524.
34. Youmans K.L., Leung S., Zhang J., Maus E., Baysac K., Bu G., Vassar R., Yu C., LaDu M.J. Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations. J Neurosci Methods 2011, 196:51-59.
35. Zhang X.-M., Cai Y., Xiong K., Cai H., Luo X.-G., Feng J.-C., Clough R.W., Struble R.G., Patrylo P.R., Yan X.-X. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur J Neurosci 2009, 30:2271-2283.
36. Zhao J., Fu Y., Yasvoina M., Shao P., Hitt B., O'Connor T., Logan S., Maus E., Citron M., Berry R., Binder L., Vassar R. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 2007, 27:3639-3649.